30 September 2025 - Voluntary agreement meets the President’s four requests while also protecting the US ecosystem responsible for America’s leadership in delivering medical breakthroughs.
Pfizer today announced a historic agreement with the Trump Administration that will ensure US patients pay lower prices for their prescription medicines while strengthening America’s role as the global leader in biopharmaceutical innovation.